Atlas Trials

Low Dose Rituximab in Thrombotic Thrombocytopenic Purpura

Clinical trial NCT01554514 · COMPLETED

Trial details

NCT number
NCT01554514
Sponsor
Washington University School of Medicine
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Thrombotic Thrombocytopenic Purpura
Start date
2012-08-01
Primary completion
2020-02-14
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.